1. Home
  2. Analysis
  3. Atenolol
  4. Asmanex-hfa

Atenolol and Asmanex hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atenolol and Asmanex hfa. Common interactions include dyspnoea among females and gastrooesophageal reflux disease among males.

The phase IV clinical study analyzes what interactions people who take Atenolol and Asmanex hfa have. It is created by eHealthMe based on reports of 13 people who take Atenolol and Asmanex hfa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 18, 2023

13 people who take Atenolol and Asmanex hfa together, and have interactions are studied.

What is Atenolol?

Atenolol has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 167,007 Atenolol users for its effectiveness, alternative drugs and more.

What is Asmanex hfa?

Asmanex hfa has active ingredients of mometasone furoate. eHealthMe is studying from 959 Asmanex hfa users for its effectiveness, alternative drugs and more.

Number of Atenolol and Asmanex hfa reports submitted per year:

Atenolol and Asmanex hfa drug interactions.

Common Atenolol and Asmanex Hfa drug interactions by gender *:

female:

  1. Dyspnoea
  2. Drug ineffective
  3. Dyspnoea exertional
  4. Panic attack
  5. Paranasal sinus hypersecretion
  6. Pharyngeal disorder
  7. Cough
  8. Asthma
  9. Blood pressure decreased
  10. Chest discomfort

male:

  1. Gastrooesophageal reflux disease
  2. Vocal cord paresis
  3. Limb discomfort
  4. Nonspecific reaction
  5. Panic attack
  6. Pneumonia
  7. Rheumatoid arthritis
  8. Surgery
  9. Wound infection
  10. Angioedema

Common Atenolol and Asmanex Hfa drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Angioedema
  2. Blood pressure decreased
  3. Surgery
  4. Cough
  5. Death
  6. Dyspnoea
  7. Fluid retention
  8. Interstitial lung disease
  9. Laryngeal oedema
  10. Malaise

Common conditions people have *:

  1. Asthma: 5 people, 38.46%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 15.38%
  3. B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 2 people, 15.38%
  4. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 15.38%
  5. Type 2 Diabetes: 1 person, 7.69%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 7.69%
  7. Bipolar Disorder (mood disorder): 1 person, 7.69%
  8. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 7.69%
  9. Erection Problems: 1 person, 7.69%
  10. Essential Hypertension (primary hypertension): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Atenolol and Asmanex hfa?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Atenolol and Asmanex hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atenolol side effects:

Browse all side effects of Atenolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atenolol interactions:

Browse all interactions between Atenolol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atenolol and mometasone furoate (the active ingredients of Atenolol and Asmanex hfa, respectively), and Atenolol and Asmanex hfa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Atenolol and Asmanex hfa.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.